LONG-TERM CARE OF THE LIVER TRANSPLANT RECIPIENT
作者： Santiago J. Munoz , Kenneth D. Rothstein , David Reich , Cosme Manzarbeitia
DOI: 10.1016/S1089-3261(05)70133-1
关键词: Complete blood count 、 Immunosuppressive drug 、 Intensive care medicine 、 Medicine 、 Management of obesity 、 Creatinine 、 Preventive healthcare 、 Blood pressure 、 Antibiotics 、 Long-term care
摘要: GENERAL PREVENTIVE MEDICINE Liver transplant recipients are generally highly motivated individuals, compliant with medical follow-up and prescribed therapeutic drugs. Visits to the physician’s office every 2 3 months provide a good opportunity implement preventive medicine measures, including monitoring of arterial blood pressure, body weight, early evaluation new complaints. Regular determination complete count, electrolytes, creatinine, glucose, liver biochemical tests, immunosuppressive drug levels should be arranged so that results forwarded center. require immunization updates, management obesity, screening for malignancies, risk factors atherosclerotic cardiovascular disease, counseling on risky behaviors appropriate use prophylactic antibiotics. The existence allograft therapy special considerations during implementation these general health measures.
elsevier.com
sci-hub.se 参考文章(107)
Röggla H, Mühlbacher F, Röggla G, Psychiatric prognostic factors in patients with alcohol-related end-stage liver disease before liver transplantation. Wiener Klinische Wochenschrift. ,vol. 108, pp. 272- 275 ,(1996)
A.J. Stellon, A. Davies, J. Compston, R. Williams, Bone loss in autoimmune chronic active hepatitis on maintenance corticosteroid therapy Gastroenterology. ,vol. 89, pp. 1078- 1083 ,(1985) , 10.1016/0016-5085(85)90212-4
L. Schwerman, M. K. Porayko, E. R. Dickson, R. A. F. Krom, S. Beaver, R. H. Wiesner, J. E. Hay, Bone disease in liver transplant recipients: incidence, timing, and risk factors. International congress of the transplantation society. ,vol. 23, pp. 1462- 1465 ,(1991)
P. Seu, A. Shaked, A. H. Wilkinson, R. W. Busuttil, The hepatorenal syndrome in liver transplant recipients. American Surgeon. ,vol. 57, pp. 806- 809 ,(1991)
Frederick Karrer, Gerhard Schroter, Igal Kam, Bahri Bilir, Greg Everson, Mark D. Stegall, Metabolic complications after liver transplantation. Diabetes, hypercholesterolemia, hypertension, and obesity. Transplantation. ,vol. 60, pp. 1057- 1060 ,(1995)
Cognitive deficits after hepatic transplantation: relevance to the rehabilitation potential. Brain Injury. ,vol. 10, pp. 599- 607 ,(1996) , 10.1080/026990596124179
B. E. Jarrell, R. O. Deems, S. J. Munoz, M. J. Moritz, P. Martin, W. C. Maddrey, Hyperlipidemia and obesity after orthotopic liver transplantation. International congress of the transplantation society. ,vol. 23, pp. 1480- 1483 ,(1991)
THOMAS A. GONWA, CHRISTINE A. MORRIS, ROBERT M. GOLDSTEIN, BO S. HUSBERG, GORAN B. KLINTMALM, Long-term survival and renal function following liver transplantation in patients with and without hepatorenal syndrome--experience in 300 patients. Transplantation. ,vol. 51, pp. 428- 430 ,(1991) , 10.1097/00007890-199102000-00030
LOUIS J ARONNE, Modern Medical Management of Obesity: The Role of Pharmaceutical Intervention Journal of The American Dietetic Association. ,vol. 98, ,(1998) , 10.1016/S0002-8223(98)00706-8
Horace E. Thompson, George W. Chapman, John B. Mailhes, Morbidity in obese and nonobese patients following gynecologic surgery for cancer. Journal of The National Medical Association. ,vol. 80, pp. 417- 420 ,(1988)